DeltaScreener covers 48 Diagnostics & Research Medical companies listed on the NYSE, NASDAQ and AMEX. The table below shows the 48 largest by market capitalisation; every figure on this page is a median across those 48, not an average, because a handful of loss-making micro-caps would otherwise distort it.
Companies48
Combined market cap$926.91B
Median P/E0.0
Median ROE0.0%
Dividend payers7 of 48
Across the largest Diagnostics & Research Medical companies, the median price-to-earnings ratio is 0.0, median return on equity is 0.0%, the median net margin is 0.0%, 7 of the 48 largest pay a dividend.
Diagnostics & Research Medical stocks — frequently asked questions
How many Diagnostics & Research Medical stocks are there?
DeltaScreener covers 48 Diagnostics & Research Medical companies on the NYSE, NASDAQ and AMEX.
What is the largest Diagnostics & Research Medical company?
Thermo Fisher Scientific Inc (TMO) is the largest Diagnostics & Research Medical company by market capitalisation, at $249.14B.
What is a typical P/E ratio for Diagnostics & Research Medical stocks?
Across the 48 largest Diagnostics & Research Medical companies the median price-to-earnings ratio is 0.0. Individual companies vary widely, and loss-making companies have no meaningful P/E at all.
Which Diagnostics & Research Medical stock has the highest dividend yield?
Qiagen N.V. (QGEN) has the highest dividend yield among Diagnostics & Research Medical stocks at 1.56%. A high yield can reflect a falling share price as much as a generous dividend.